World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
69
Citations
29964
World Ranking
7236
National Ranking
3319

Christopher R. Vakoc publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Christopher R. Vakoc sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 207 publications — 53rd percentile

53% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Christopher R. Vakoc D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Christopher R. Vakoc sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 69 D-Index — 63rd percentile

63% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Research.com Recognitions

  • 2019 - Paul Marks Prize for Cancer Research, Memorial Sloan Kettering Cancer Center

Overview

Christopher R. Vakoc is affiliated with the Cold Spring Harbor Laboratory in the United States. Their research spans multiple fields with a primary focus on Biochemistry, Genetics and Molecular Biology, and Medicine.

The scientist's work predominantly explores Molecular Biology, Oncology, Cancer Research, Immunology, and Hematology. Key topics addressed in their research include:

  • Protein Degradation and Inhibitors
  • Epigenetics and DNA Methylation
  • Chromatin Remodeling and Cancer
  • Histone Deacetylase Inhibitors Research
  • Pancreatic and Hepatic Oncology Research
  • Acute Myeloid Leukemia Research
  • Genomics and Chromatin Dynamics

Christopher R. Vakoc's recent published works consist of the following papers:

  • New Approaches to SCLC Therapy: From the Laboratory to the Clinic, 2020, Journal of Thoracic Oncology
  • Chronic stress increases metastasis via neutrophil-mediated changes to the microenvironment, 2024, Cancer Cell
  • Intraductal Transplantation Models of Human Pancreatic Ductal Adenocarcinoma Reveal Progressive Transition of Molecular Subtypes, 2020, Cancer Discovery
  • SOAT1 promotes mevalonate pathway dependency in pancreatic cancer, 2020, The Journal of Experimental Medicine
  • Squamous trans-differentiation of pancreatic cancer cells promotes stromal inflammation, 2020, eLife

Frequent coauthors collaborating with Christopher R. Vakoc include:

  • Olaf Klingbeil
  • Xiaoli Wu
  • Kenneth Chang
  • Osama E. Demerdash
  • David A. Tuveson

The scientist's work often appears in reputable academic venues, with multiple publications in:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Cancer Research
  • Cancer Discovery
  • Nature Communications
  • Cancer Cell

Christopher R. Vakoc has been recognized with the Paul Marks Prize for Cancer Research from Memorial Sloan Kettering Cancer Center in 2019.

Best Publications

  • BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc

    Jake E. Delmore;Ghayas C. Issa;Madeleine E. Lemieux;Peter B. Rahl

  • Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers

    Jakob Lovén;Heather A. Hoke;Charles Y. Lin;Charles Y. Lin;Ashley Lau

  • RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia

    Johannes Zuber;Junwei Shi;Junwei Shi;Eric Wang;Amy R. Rappaport;Amy R. Rappaport

  • Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data.

    Charles M. Rudin;John T. Poirier;Lauren Averett Byers;Caroline Dive

  • Promoter-bound METTL3 maintains myeloid leukaemia by m 6 A-dependent translation control

    Isaia Barbieri;Konstantinos Tzelepis;Luca Pandolfini;Junwei Shi

  • The Mechanisms behind the Therapeutic Activity of BET Bromodomain Inhibition

    Junwei Shi;Christopher R. Vakoc

  • Organoid profiling identifies common responders to chemotherapy in pancreatic cancer

    Hervé Tiriac;Pascal Belleau;Dannielle D Engle;Dennis Plenker

  • Histone H3 Lysine 9 Methylation and HP1γ Are Associated with Transcription Elongation through Mammalian Chromatin

    Christopher R. Vakoc;Sean A. Mandat;Benjamin A. Olenchock;Gerd A. Blobel;Gerd A. Blobel

  • Discovery of cancer drug targets by CRISPR-Cas9 screening of protein domains

    Junwei Shi;Eric Wang;Joseph P. Milazzo;Zhihua Wang

  • Proximity among Distant Regulatory Elements at the β-Globin Locus Requires GATA-1 and FOG-1

    Christopher R. Vakoc;Danielle L. Letting;Danielle L. Letting;Nele Gheldof;Tomoyuki Sawado

  • DOT1L/KMT4 recruitment and H3K79 methylation are ubiquitously coupled with gene transcription in mammalian cells.

    David J. Steger;Martina I. Lefterova;Lei Ying;Aaron J. Stonestrom

  • Transcriptional plasticity promotes primary and acquired resistance to BET inhibition

    Philipp Rathert;Mareike Roth;Tobias Neumann;Felix Muerdter

  • Global regulation of erythroid gene expression by transcription factor GATA-1

    John J. Welch;Jason A. Watts;Christopher R. Vakoc;Yu Yao

  • Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation

    Junwei Shi;Warren A. Whyte;Cinthya J. Zepeda-Mendoza;Cinthya J. Zepeda-Mendoza;Joseph P. Milazzo

  • Profile of histone lysine methylation across transcribed mammalian chromatin

    Christopher R. Vakoc;Mira M. Sachdeva;Hongxin Wang;Gerd A. Blobel;Gerd A. Blobel

  • Enhancer Reprogramming Promotes Pancreatic Cancer Metastasis

    Jae Seok Roe;Chang Il Hwang;Chang Il Hwang;Tim D.D. Somerville;Joseph P. Milazzo

  • BRD4 Connects Enhancer Remodeling to Senescence Immune Surveillance

    Nilgun Tasdemir;Ana Banito;Jae Seok Roe;Direna Alonso-Curbelo

  • BET Bromodomain Inhibition Suppresses the Function of Hematopoietic Transcription Factors in Acute Myeloid Leukemia.

    Jae Seok Roe;Fatih Mercan;Keith Rivera;Darryl J. Pappin

  • POU2F3 is a master regulator of a tuft cell-like variant of small cell lung cancer.

    Yu-Han Huang;Olaf Klingbeil;Xue-Yan He;Xiaoli S. Wu;Xiaoli S. Wu

  • The ubiquitin ligase FBXW7 modulates leukemia-initiating cell activity by regulating MYC stability.

    Bryan King;Thomas Trimarchi;Linsey Reavie;Linsey Reavie;Luyao Xu

Frequent Co-Authors

Gerd A. Blobel
Gerd A. Blobel Children's Hospital of Philadelphia
Scott W. Lowe
Scott W. Lowe Memorial Sloan Kettering Cancer Center
Johannes Zuber
Johannes Zuber Research Institute of Molecular Pathology
David A. Tuveson
David A. Tuveson Cold Spring Harbor Laboratory
James E. Bradner
James E. Bradner Amgen (United States)
Mitchell J. Weiss
Mitchell J. Weiss St. Jude Children's Research Hospital
Peter Valent
Peter Valent Medical University of Vienna
W. Richard McCombie
W. Richard McCombie Cold Spring Harbor Laboratory
Ross C. Hardison
Ross C. Hardison Pennsylvania State University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Biology and Biochemistry in the USA opens the door to a variety of rewarding career options, including rapidly growing fields like health information management and medical coding. As healthcare systems increasingly rely on digital data, certified professionals are in high demand.

For those interested in bridging biology with technology, pursuing a bachelor's degree health information management can offer affordable online pathways to careers managing patient records and healthcare data systems. Medical coding is another popular career, focused on translating medical procedures into universal codes. Many ask, how long does it take to become a medical coder? The answer varies, but flexible training options make it accessible to diverse learners.

When considering industry credentials, it's important to understand the differences between ccs certification and other coding certifications. Each offers unique career and salary prospects within healthcare. Still uncertain about the field? Learn more by exploring is medical coding a good career to weigh both the benefits and challenges. These online degrees and certifications can pave the way for impactful roles in biology, healthcare, and beyond.

Best Scientists Citing Christopher R. Vakoc

Trending Scientists